Engineering ferroptosis radiosensitizer for SPARC-targeted degradation: A strategy to reverse radioresistant non-small cell lung cancer
- 2 September 2025
- journal article
- Published by Elsevier in Biomaterials
- Vol. 326, 123675
Abstract
No abstract availableKeywords
Funding Information
- Jilin University (2023B09)
- National Natural Science Foundation of China (52371254)
- People's Government of Jilin Province (YDZJ202402068CXJD)
This publication has 51 references indexed in Scilit:
- Radiation-triggerable bioreactors enable bioenergetic reprograming of cancer stem cell plasticity via targeted arginine metabolism disruption for augmented radio-immunotherapyBiomaterials, 2025
- The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventionsCancer Cell, 2024
- Interference with SPARC inhibits Benzophenone-3 induced ferroptosis in osteoarthritis: Evidence from bioinformatics analyses and biological experimentationEcotoxicology and Environmental Safety, 2024
- Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistanceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- Ferroptosis Detection: From Approaches to ApplicationsAngewandte Chemie International Edition, 2023
- NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancerApoptosis, 2022
- Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updatesCancer Communications, 2021
- Ferroptosis, radiotherapy, and combination therapeutic strategiesProtein & Cell, 2021
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapyProtein & Cell, 2020
- Glutathione Peroxidase 4 Senses and Translates Oxidative Stress into 12/15-Lipoxygenase Dependent- and AIF-Mediated Cell DeathCell Metabolism, 2008